Literature DB >> 31316321

Risk of SOFA Deterioration in Conservative Treatment for Emphysematous Pyelonephritis: Pitfalls of Current Trends in Therapeutics from Multicenter Clinical Experience.

Michinobu Ozawa1,2, Osamu Ichiyanagi3, Suguru Fujita3,4, Sei Naito3, Hiroki Fukuhara3,4, Shinta Suenaga5, Satoshi Takai1, Takafumi Narisawa1,3, Noriyuki Hosoya6, Tatsuya Ishii7,8, Takuya Yamanobe3,6, Akinori Muto9, Hitoshi Suzuki8, Hayato Nishida3, Tomoyuki Kato3, Norihiko Tsuchiya3.   

Abstract

INTRODUCTION: We investigated relationships between therapeutic outcomes of patients with emphysematous pyelonephritis (EPN) and changes in the Sequential Organ Failure Assessment (SOFA) score.
MATERIALS AND METHODS: We retrospectively evaluated EPN patients treated in our hospitals using the SOFA score incorporated in the Sepsis-3 updated in 2016.
RESULTS: Seventeen typical EPN patients were included in this study, and were treated with medical management with no drainage (n = 3), retrograde stenting (n = 10), or percutaneous drainage (n = 3). One patient without drainage died of sepsis, yielding an overall mortality rate of 5.9%. Twelve patients recovered without increase in the SOFA score during hospitalization. However, the SOFA score deteriorated in the other patients from admission, with the initial scores not significantly different from those of the 12 cases. The changes in the SOFA score were significantly affected by the selected approaches of drainage (100% patients for no drainage, 22% for stenting, and 0% for percutaneous drainage, p = 0.029), but not by other clinical data.
CONCLUSION: Most EPN patients can currently be conservatively managed successfully. However, it should be noted that less-invasive management could cause deterioration in SOFA after admission, yielding a risk of septic mortality.

Entities:  

Keywords:  Drainage; Emphysematous pyelonephritis; SOFA; Sepsis; Stenting

Year:  2019        PMID: 31316321      PMCID: PMC6613313          DOI: 10.1159/000489431

Source DB:  PubMed          Journal:  Curr Urol        ISSN: 1661-7649


  27 in total

Review 1.  The pathophysiology and treatment of sepsis.

Authors:  Richard S Hotchkiss; Irene E Karl
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

2.  Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis.

Authors:  J J Huang; C C Tseng
Journal:  Arch Intern Med       Date:  2000-03-27

3.  Determination of PO2 from saturation.

Authors:  R K Ellis
Journal:  J Appl Physiol (1985)       Date:  1989-08

4.  Acute gas-producing bacterial renal infection: correlation between imaging findings and clinical outcome.

Authors:  Y L Wan; T Y Lee; M J Bullard; C C Tsai
Journal:  Radiology       Date:  1996-02       Impact factor: 11.105

Review 5.  Emphysematous pyelonephritis.

Authors:  Sarvpreet Singh Ubee; Laura McGlynn; Mark Fordham
Journal:  BJU Int       Date:  2010-09-14       Impact factor: 5.588

6.  [Results of conservative management of emphysematous pyelonephritis].

Authors:  Ahmed Saadi; Haroun Ayed; Abderrazak Bouzouita; Mohamed Cherif; Walid Kerkeni; Selim Selmi; Riadh Ben Slama; Amine Derouiche; Mohamed Chebil
Journal:  Nephrol Ther       Date:  2016-10-24       Impact factor: 0.722

7.  Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis.

Authors:  Rakesh Kapoor; Kaliyaperumal Muruganandham; Anil Kumar Gulia; Manish Singla; Saurabh Agrawal; Anil Mandhani; M S Ansari; Aneesh Srivastava
Journal:  BJU Int       Date:  2009-11-20       Impact factor: 5.588

8.  Emphysematous pyelonephritis: multicenter clinical and therapeutic experience in Mexico.

Authors:  Daniel Olvera-Posada; Ghislaine Armengod-Fischer; Luis G Vázquez-Lavista; Miguel Maldonado-Ávila; Emmanuel Rosas-Nava; Hugo Manzanilla-García; Ricardo A Castillejos-Molina; Carlos E Méndez-Probst; Mariano Sotomayor; Guillermo Feria-Bernal; Francisco Rodríguez-Covarrubias
Journal:  Urology       Date:  2014-04-13       Impact factor: 2.649

9.  Risk factors for mortality in patients with emphysematous pyelonephritis: a meta-analysis.

Authors:  Matthew E Falagas; Vangelis G Alexiou; Konstantina P Giannopoulou; Ilias I Siempos
Journal:  J Urol       Date:  2007-07-16       Impact factor: 7.450

10.  Double J stenting: A rewarding option in the management of emphysematous pyelonephritis.

Authors:  Debiprasad Das; Dilip Kumar Pal
Journal:  Urol Ann       Date:  2016 Jul-Sep
View more
  1 in total

Review 1.  Prevalence and Risk Factors of Mortality in Emphysematous Pyelonephritis Patients: A Meta-Analysis.

Authors:  Xuan Thai Ngo; Tuan Thanh Nguyen; Ryan W Dobbs; Minh Sam Thai; Duc Huy Vu; Le Quy Van Dinh; Khoa Quy; Hieu Trong Le; Tien-Dat Hoang; Hanh Thi Tuyet Ngo; Trinh Ngoc Khanh Van; Ho Yee Tiong; Huy Gia Vuong
Journal:  World J Surg       Date:  2022-07-08       Impact factor: 3.282

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.